WebbAcute coronary syndrome (ACS) encompasses a spectrum of conditions which include myocardial infarction with or without ST-segment-elevation (STEMI or NSTEMI respectively), and unstable angina. These result from the formation of a thrombus on an atheromatous plaque in a coronary artery, and while the presentation and management … WebbWe have developed a novel mnemonic, 'THROMBINS2' (thienopyridines, heparin/enoxaparin, renin-angiotensin system blockers, oxygen, morphine, beta blocker, intervention, nitroglycerin, statin/salicylate) to help bedside clinicians recall all the elements of contemporary ACS management. We demonstrate the mortality benefit …

The Death of MONA in ACS: Part IV - Aspirin - REBEL EM

WebbLow-dose intravenous (IV) nitroglycerin (NTG) infusion for the first 48 h after acute MI, titrated to lower mean blood pressure by 10% to 30%, but not below 80 mmHg, has … WebbNitroglycerin (glyceryl trinitrate [GTN]) remains a first-line treatment for angina pectoris and acute MI. Nitroglycerin achieves its benefit by giving rise to nitric oxide (NO), which … coquihalla highway

Part 7: The Era of Reperfusion Circulation

WebbTherapy with a combination of antiplatelets, statins, beta blockers, and ACE inhibitors has been shown to decrease mortality at six months in patients with ACS, with incremental benefit as... WebbNitroglycerin acts as a venodilator to decrease venous return to the heart, which then decreases left ventricular workload and myocardial oxygen demand. At the same time, the coronary artery dilatory effects help deliver oxygen to ischemic areas in the myocardium. WebbThe benefits of dual antiplatelet therapy in decreasing the combined end points of cardiovascular mortality, subsequent MI, and stroke were noted at 30 days through 12 … coquitlam air quality index